ロード中...
Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis
Multiple myeloma (MM) is the second most frequent hematologic cancer in the United States. Carfilzomib (CFZ), an irreversible proteasome inhibitor being used to treat relapsed and refractory MM, has been associated with cardiotoxicity, including heart failure. We hypothesized that a multi-omics appr...
保存先:
| 出版年: | Front Cardiovasc Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8116486/ https://ncbi.nlm.nih.gov/pubmed/33996940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.645122 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|